Register entry

Ocular Therapeutix, Inc.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
5
Exclusivities
1
Countries
1
Base
United States
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Ocular Therapeutix, Inc.36 Crosby Drive, Suite 101, Bedford, Massachusetts (MA) 01730, United States (USA)Finished drug manufacture3008477155080122594
Exclusivity

Patents and exclusivities

5
PatentProductCoversExpiry
8563027DEXTENZAdexamethasoneuseFeb 2030
8409606DEXTENZAdexamethasoneproductMay 2030
12150896DEXTENZAdexamethasoneuseOct 2036
11458041DEXTENZAdexamethasoneuseNov 2037
12144889DEXTENZAdexamethasoneuseApr 2041
ProductExclusivityUntil
DEXTENZADEXAMETHASONENPP New patient populationApr 2028
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
DEXTENZAdexamethasoneinsert, intracanalicular, ophthalmic70382-204NDA
Neighbours

Registered in the same town

2
Compare

Comparable companies in United States

Enquiry

Common questions

Is Ocular Therapeutix, Inc. FDA approved?
Ocular Therapeutix, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Ocular Therapeutix, Inc.'s drugs manufactured?
The FDA register lists Bedford, MA. Registered operations: finished drug manufacture.
What drugs does Ocular Therapeutix, Inc. make?
1 product is listed under Ocular Therapeutix, Inc. in the openFDA NDC Directory, most often as insert. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.